Tag: Jubilant Pharmova
Jubilant Pharmova – Q3 & 9M’FY26 results
The Board of Jubilant Pharmova Limited recently met to approve financial results for the quarter and nine months ended 31 December 2025.
3FY26 Key highlights
Solid...
Jubilant seeks DGCI authorization for oral Remdesivir next steps
On 19 April 2021, Noida-Delhi NCR-based Jubilant Pharmova announced the development of a novel oral formulation of Remdesivir by its subsidiary Jubilant Pharma with...